BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6410481)

  • 1. [Laboratory diagnosis of depressive disorders].
    Linkowski P
    Rev Med Brux; 1983 Apr; 4(4):229-33. PubMed ID: 6410481
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroendocrine predictors of the antidepressant effect of partial sleep deprivation.
    Joffe R; Brown P; Bienenstock A; Mitton J
    Biol Psychiatry; 1984 Mar; 19(3):347-52. PubMed ID: 6426532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Towards an attempt at biological differentiation of endogenous and exogenous depression: a study of beta-endorphins and other parameters (prolactin, growth hormone and dexamethasone repression test) in a cohort of ambulatory depressed patients].
    Gallart JM; Galard R; Catalan R; Arguello JM; Castellanos JM; Schwartz S
    Ann Med Psychol (Paris); 1988; 146(8):758-63. PubMed ID: 2977276
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute hospitalization on the dexamethasone suppression and TRH stimulation tests.
    Roy-Byrne P; Gwirtsman H; Sternbach H; Gerner RH
    Biol Psychiatry; 1984 Apr; 19(4):607-12. PubMed ID: 6428471
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in hormonal indicators during the treatment of depression of different types].
    Krasnov VI; Kokhanenko EM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):101-5. PubMed ID: 2750367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI; Halaris A; Baxter L; Schwarcz G; Thompson M; Hurwicz ML; Hill M; Young M; Daugherty K; Clemens A
    Psychopharmacol Bull; 1985; 21(1):77-80. PubMed ID: 3920706
    [No Abstract]   [Full Text] [Related]  

  • 9. Subtypes and laboratory measures of autonomous depression.
    Friedel RO
    J Clin Psychiatry; 1982 Aug; 43(8 Pt 2):28-31. PubMed ID: 6807967
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroendocrine abnormalities in affective disorders.
    Extein I; Pottash AL; Gold MS
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychoneuroendocrinology].
    Holsboer F
    Internist (Berl); 1985 May; 26(5):302-8. PubMed ID: 2989208
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on pituitary function in patients with B-cell adenoma.
    Zaccaria M; Giordano G; Vettor R; Ragazzi E; Boscaro M; Federspil G; Scandellari C
    Horm Metab Res; 1983 Nov; 15(11):562-3. PubMed ID: 6317536
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of the dexamethasone suppression test].
    De Leo D; Capodieci S
    Minerva Psichiatr; 1984; 25(2):115-25. PubMed ID: 6436632
    [No Abstract]   [Full Text] [Related]  

  • 14. The thyrotropin releasing hormone stimulation test: a review.
    Sternbach H; Gerner RH; Gwirtsman HE
    J Clin Psychiatry; 1982 Jan; 43(1):4-6. PubMed ID: 6798028
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical psychiatry conference: biological and family indicators in depression.
    Baer RK; Muecke MM; Nasr S; Lahmeyer HW; Gaviria FM; Dysken MW; Akiskal HS; Dilsaver SC; Greden JF
    J Clin Psychiatry; 1983 Oct; 44(10):372-8. PubMed ID: 6417114
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
    Laakmann G
    Nervenarzt; 1980; 51(12):725-32. PubMed ID: 7207684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biologic diagnosis of depression by the TRH and dexamethasone tests].
    Chabrol H; Moron P
    Encephale; 1983; 9(1):1-22. PubMed ID: 6135596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD
    Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of neuroendocrine tests in the diagnosis of depressive disorders].
    Cervera S; Gurpegui M; Casanova J; Lahortiga F; Zapata R
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1983; 11(5):345-62. PubMed ID: 6419550
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical correlates of the TRH infusion test in primary depression.
    Kirstein L; Gold MS; Extein I; Martin D; Pottash AL
    J Clin Psychiatry; 1982 May; 43(5):191-4. PubMed ID: 6804446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.